Abstract:Background: Gene promoter methylation is a major epigenetic change in cancers, which plays critical roles in carcinogenesis. As a crucial regulator in the early stages of B-cell differentiation and embryonic neurodevelopment, the paired box 5 (PAX5) gene is downregulated by methylation in several kinds of tumors and the role of this downregulation in esophageal squamous cell carcinoma (ESCC) pathogenesis remains unclear. Methods: To elucidate the role of PAX5 in ESCC, eight ESCC cell lines, 51 primary ESCC tissue samples, and eight normal esophageal mucosa samples were studied and The Cancer Genome Atlas (TCGA) was queried. PAX5 expression was examined by reverse transcription-polymerase chain reaction and western blotting. Cell apoptosis, proliferation, and chemosensitivity were detected by flow cytometry, colony formation assays, and 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2-H-tetrazolium bromide assays in ESCC cell lines with PAX5 overexpression or silencing. Tumor xenograft models were established for in vivo verification. Results: PAX5 methylation was found in 37.3% (19/51) of primary ESCC samples, which was significantly associated with age (P = 0.007) and tumor-node-metastasis stage (P = 0.014). TCGA data analysis indicated that PAX5 expression was inversely correlated with promoter region methylation (r = -0.189, P = 0.011 for cg00464519 and r = -0.228, P = 0.002 for cg02538199). Restoration of PAX5 expression suppressed cell proliferation, promoted apoptosis, and inhibited tumor growth of ESCC cell lines, which was verified in xenografted mice. Ectopic PAX5 expression significantly increased p53 reporter luciferase activity and increased p53 messenger RNA and protein levels. A direct interaction of PAX5 with the p53 promoter region was confirmed by chromatin immunoprecipitation assays. Re-expression of PAX5 sensitized ESCC cell lines KYSE150 and KYSE30 to fluorouracil and docetaxel. Silencing of PAX5 induced resistance of KYSE450 cells to these drugs. Conclusions: As a tumor suppressor gene regulated by promoter region methylation in human ESCC, PAX5 inhibits proliferation, promotes apoptosis, and induces activation of p53 signaling. PAX5 may serve as a chemosensitive marker of ESCC.

Paired Box 5 is a Frequently Methylated Lung Cancer Tumour Suppressor Gene Interfering Β‐catenin Signalling and GADD45G Expression

Paired Box 5 is a Novel Marker of Breast Cancers That is Frequently Downregulated by Methylation

Paired Box 5 Increases the Chemosensitivity of Esophageal Squamous Cell Cancer Cells by Promoting P53 Signaling Activity

Association of Abnormal Methylation of CpG Islands in Promoter Domains of Multiple Tumor Suppressor Genes with Non-Small Cell Lung Cancer

Protocadherin 10 is Frequently Downregulated by Promoter Methylation and Functions As a Tumor Suppressor Gene in Non-Small Cell Lung Cancer.

The Epigenetic Modifier PRDM5 Functions As a Tumor Suppressor Through Modulating WNT/β-catenin Signaling and is Frequently Silenced in Multiple Tumors.

PAX9 in Cancer Development

Epigenetic Inactivation of Bcl6b, A Novel Functional Tumour Suppressor for Gastric Cancer, is Associated with Poor Survival

Epigenetic identification of CHD5 as a critical 1p36.3 tumor suppressor frequently inactivated by promoter methylation in multiple carcinomas

The PAX6-ZEB2 Axis Promotes Metastasis and Cisplatin Resistance in Non-Small Cell Lung Cancer Through PI3K/AKT Signaling.

Reactivation of methylation‐silenced PAX1 inhibits cervical cancer proliferation and migration via the WNT/TIMELESS pathway

UNC5A, an epigenetically silenced gene, functions as a tumor suppressor in non-small cell lung cancer

Promoter Methylation of Wnt/β-Catenin Signal Inhibitor TMEM88 is Associated with Unfavorable Prognosis of Non-Small Cell Lung Cancer.

Hypermethylation of the PTTG1IP Promoter Leads to Low Expression in Early-Stage Non-Small Cell Lung Cancer

Infrequently methylated event at sites −362 to −142 in the promoter of TGFβR1 gene in non-small cell lung cancer

Promoter Methylation-Mediated Downregulation of PRDM5 Contributes to the Development of Lung Squamous Cell Carcinoma.

Defective Expression Of Transforming Growth Factor Beta Receptor Type Ii Is Associated With Cpg Methylated Promoter In Primary Non-Small Cell Lung Cancer

Applicability of the Methylated Cpg Sites of Paired Box 5 (pax5) Promoter for Prediction the Prognosis of Gastric Cancer

Infrequently Methylated Event At Sites-362 To-142 In The Promoter Of Tgf Beta R1 Gene In Non-Small Cell Lung Cancer

PDS5B inhibits cell proliferation, migration, and invasion via upregulation of LATS1 in lung cancer cells

Promoter Methylation of TCF21 May Repress Autophagy in the Progression of Lung Cancer.